Sickle hemoglobin (Hb S) allele and sickle cell disease: A HuGE review

American Journal of Epidemiology

Volumn 151, Issue 9, 2000, Pages 839-845

  Ashley Koch, Allison ^a,c   Yang, Q ^b   Olney, R S ^b  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anemia, sickle cell; Epidemiology; Genetics; Hemoglobin, sickle; Hq S; Public health; Sickle cell trait

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN S; GLOBIN;

AGAR GEL ELECTROPHORESIS; ALPHA THALASSEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOELECTRIC FOCUSING; MALARIA; MORTALITY; REVIEW; SICKLE CELL ANEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLELE; CARDIOVASCULAR DISEASE; CHILD; COMORBIDITY; FEMALE; GENETIC SCREENING; GENETICS; HAPLOTYPE; INFANT; LEGAL ASPECT; MALARIA FALCIPARUM; MALE; NEWBORN; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; SEX RATIO; SURVIVAL RATE; THORAX PAIN; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLELES; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; CARDIOVASCULAR DISEASES; CHEST PAIN; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FETAL HEMOGLOBIN; GENETIC SCREENING; GLOBINS; HAPLOTYPES; HEMOGLOBIN, SICKLE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; PNEUMONIA; PREVALENCE; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 0034178262     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010288     Document Type: Review

References (27)

1. Online Mendelian Inheritance in Man (OMIM). Hemoglobin-beta locus (HBB). (MIM no. 141900). Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, August 12, 1999. (World Wide Web URL: http://www.ncbi.nlm.nih.gov/ htbin-post/Omim/dispmim?141900).
2. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants. (Clinical Practice Guideline no. 6). Rockville, MD: Agency for Health Care Policy and Research, US Public Health Service, 1993. (AHCPR publication no. 93-0562).
3. Lorey FW, Amopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol 1996;13:501-12.
4. Kark JA, Posey DM, Schumacher HR, et al. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987;317:781-7.
5. Aluoch JR. Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Trop Med Int Health 1997;2:568-71.
6. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991;325: 11-16.
7. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9.
8. Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 1997;112:40-3.
9. Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol 1986;124:161-79.
10. World Health Organization. International classification of diseases. International statistical classification of diseases, injuries, and causes of death. Ninth Revision. Geneva, Switzerland: World Health Organization, 1977.
11. Deardorff KE, Hollman FW, Montgomery P. U.S. population estimates by age, sex, race, and Hispanic origin: 1990 to 1994. (PPL-21). Washington, DC: Bureau of the Census, US Department of Agriculture, 1995. (http://www.census.gov/ population/estimates/state/sasrh_doc.txt).
12. Leiken SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease: Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84:500-8.
13. Mortality among children with sickle cell disease identified by newborn screening during 1990-1994 - California, Illinois, and New York. MMWR Morb Mortal Wkly Rep 1998;47: 169-72.
14. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
15. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease: Cooperative Study of Sickle Cell Disease. Blood 1995;86: 776-83.
16. Ballas SK, Lewis CN, Noone AM, et al. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol 1982;13:37-51.
17. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
18. Nagel RL, Ranney HM. Genetic epidemiology of structural mutations of the beta-globin gene. Semin Hematol 1990;27: 342-59.
19. Powars D, Hiti A. Sickle cell anemia: beta s gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child 1993;147:1197-202.
20. Thomas PW, Higgs DR, Serjeant GR. Benign clinical course in homozygous sickle cell disease: a search for predictors. J Clin Epidemiol 1997;50:121-6.
21. Chang YP, Maier-Redelsperger M, Smith KD, et al. The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for beta S haplotypes. Br J Haematol 1997;96:806-14.
22. Lorey F, Cunningham G, Shafer F, et al. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens. Eur J Hum Genet 1994;2:262-71.
23. Aluoch JR. The presence of sickle cells in the peripheral blood film: specificity and sensitivity of diagnosis of homozygous sickle cell disease in Kenya. Trop Geogr Med 1995;47:89-91.
24. National Sickle Cell Anemia Control Act. Washington, DC: US Congress, 1972. (Public Law no. 92-294, 86 Statute 138 (May 16, 1972)).
25. Newborn Screening Committee, Council of Regional Networks for Genetic Services (CORN). National Newborn Screening Report - 1993. Atlanta, GA: Council of Regional Networks for Genetic Services, 1998.
26. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986;314:1593-9.
27. Consensus conference: newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 1987;258:1205-9.